Appropriateness of care in superficial venous disease.


Journal

Seminars in vascular surgery
ISSN: 1558-4518
Titre abrégé: Semin Vasc Surg
Pays: United States
ID NLM: 8809602

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 25 01 2024
revised: 20 05 2024
accepted: 24 05 2024
medline: 17 8 2024
pubmed: 17 8 2024
entrez: 16 8 2024
Statut: ppublish

Résumé

Chronic superficial venous disease, including superficial venous insufficiency, superficial venous thrombosis, and aneurysms, are prevalent conditions that affect millions of individuals worldwide. With chronic venous insufficiency specifically, the advent of office-based minimally invasive procedures in recent decades has significantly expanded access to outpatient treatment. However, as venous insufficiency is rarely life- or limb-threatening, the clinical diagnosis, diagnostic evaluation, and treatment indications should be considered carefully when recommending elective intervention. Appropriateness of care guidelines intend to aid providers and patients in the decision-making process, based on the available evidence in the scientific literature, to select the best care for the patient when treating their superficial venous disease.

Identifiants

pubmed: 39151994
pii: S0895-7967(24)00032-2
doi: 10.1053/j.semvascsurg.2024.05.005
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

150-155

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Misaki M. Kiguchi discloses the following: speaker's bureau of Boston Scientific and Medtronic. The remaining author discloses no conflicts.

Auteurs

Misaki M Kiguchi (MM)

Department of Vascular Surgery, MedStar Washington Hospital Center, Washington, DC. Electronic address: Misaki.m.kiguchi@medstar.net.

Bianca Cutler (B)

Division of Vascular Surgery, Beth Israel Deaconess Medical Center Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH